Gene amplifications in osteosarcoma-CGH microarray analysis.
about
Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate TherapiesRole of calcium, vitamin D, and the extrarenal vitamin D hydroxylases in carcinogenesisChildren's Oncology Group's 2013 blueprint for research: bone tumorsComparative proteomic analysis of osteosarcoma cell and human primary cultured osteoblastic cell.Histone 3.3 hotspot mutations in conventional osteosarcomas: a comprehensive clinical and molecular characterization of six H3F3A mutated cases.Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model.An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets.Biomarkers in Osteosarcoma.Identification of novel candidate oncogenes in chromosome region 17p11.2-p12 in human osteosarcoma.Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data.Ladder-like amplification of the type I interferon gene cluster in the human osteosarcoma cell line MG63Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression.The genetics of osteosarcoma.Duplication of Subcytoband 11E2 of Chromosome 11 Is Regularly Associated with Accelerated Tumor Development in v-abl/myc-Induced Mouse Plasmacytomas.Intrastrand annealing leads to the formation of a large DNA palindrome and determines the boundaries of genomic amplification in human cancerAdvances in sarcoma genomics and new therapeutic targets.Predictive properties of DNA methylation patterns in primary tumor samples for osteosarcoma relapse status.Discovery of biomarkers for osteosarcoma by proteomics approachesGene translocations in musculoskeletal neoplasms.The role of serine/threonine protein phosphatase type 5 (PP5) in the regulation of stress-induced signaling networks and cancerEtiology of specific molecular alterations in human malignancies.Recurrent RECQL4 imbalance and increased gene expression levels are associated with structural chromosomal instability in sporadic osteosarcomaInfluence of genetic background on tumor karyotypes: evidence for breed-associated cytogenetic aberrations in canine appendicular osteosarcoma.Role of the WWOX tumor suppressor gene in bone homeostasis and the pathogenesis of osteosarcoma.Genome-wide analyses on high-grade osteosarcoma: making sense of a genomically most unstable tumor.Advances in the identification of molecular markers for bone neoplasia.Genetic sharing with coronary artery disease identifies potential novel loci for bone mineral density.The Scandinavian Sarcoma Group: 30 years' experience.Array comparative genomic hybridization reveals frequent alterations of G1/S checkpoint genes in undifferentiated pleomorphic sarcoma of bone.Matrix-Gla protein promotes osteosarcoma lung metastasis and associates with poor prognosis.Prognostic significance of NDRG1 expression in oral and oropharyngeal squamous cell carcinoma.Frequent deletion of CDKN2A and recurrent coamplification of KIT, PDGFRA, and KDR in fibrosarcoma of bone--an array comparative genomic hybridization study.
P2860
Q26782646-97CF81CB-3569-4331-A206-DD9F13EEC2ABQ27011538-15B1DF4C-DE1C-4A71-A9D7-365860761D5FQ27027664-162DEFCE-724C-461B-89D5-B39C89B8108FQ33408587-0CEFE87D-C9BB-4795-A7AD-B50F36E7B132Q33640720-98317106-7333-4412-98CA-E6A2CC9B3B00Q33646069-FC74E39E-D7A9-4E10-8E3C-0B1705A6F9CBQ33692066-E8EB6CAD-9F0F-494E-8CA2-78513BA1E73FQ33929072-162F2340-2CBB-4D2E-BE6E-492BCF52EF81Q34146537-CAF34BAF-1D6F-4171-A078-9288C3690490Q34210358-10D6F7FF-E3F6-474E-AA2A-A6491B10FA56Q34344422-D87F7951-7D0B-477F-B0C6-38BA91255027Q34570006-50C56AB5-AED3-4474-A945-E8D5524AA733Q34639086-A80E3002-2A2F-4896-A9E5-A9AEC20335D5Q34972481-365EE0C1-2AAE-4CE7-B35E-7309B252D9ACQ35676289-9A08AE27-B160-4DB4-9629-59F1BD692AA0Q35993346-287491AA-2291-437E-846D-A61D82CA6B81Q36211310-E70F35F2-0E93-42B0-9BA3-486EF5B3B3C6Q36440338-6B1BA28B-294A-45CA-8398-41F6D888C69FQ36803632-715839AF-587E-4390-832C-AE818631458EQ36804492-D2448879-CBFD-4BB2-AFF0-248F2028AAABQ37000294-BEB57F9B-FBDC-4054-9595-606ABABBBB3AQ37109546-91D04F57-502C-414F-A532-5641CD0B30BEQ37136952-4D93E705-B933-4A7C-A83B-4A76D075F6CBQ37897986-4DA626D5-9252-42D8-9C52-0B250538DC11Q38084245-1E9B7F0C-2442-4DD6-BD60-11BDE38CDE3EQ38089888-4B71C11B-49D1-4539-86FB-751CDF68E91AQ38708276-FE25B71F-0D20-4B17-83E6-4AC65BEBE713Q43589203-627207A6-CB63-485B-B61B-ECC1FAB06E0CQ45125767-11B3BF63-A742-4C86-8535-3A486CE04E66Q50853780-6299E5AA-3342-46D0-B46C-583808ADED0CQ53145771-C3A804C7-F4AD-4CFE-99D6-028C5059D23CQ54712822-2341609D-F153-4F9B-B50F-F30E8861061C
P2860
Gene amplifications in osteosarcoma-CGH microarray analysis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Gene amplifications in osteosarcoma-CGH microarray analysis.
@en
type
label
Gene amplifications in osteosarcoma-CGH microarray analysis.
@en
prefLabel
Gene amplifications in osteosarcoma-CGH microarray analysis.
@en
P2093
P2860
P356
P1476
Gene amplifications in osteosarcoma-CGH microarray analysis.
@en
P2093
Aarne Kivioja
Jassu Atiye
Maija Tarkkanen
Maija Wolf
Outi Monni
Sakari Knuutila
Sippy Kaur
Tom Böhling
P2860
P304
P356
10.1002/GCC.20120
P577
2005-02-01T00:00:00Z